Vanda Pharmaceuticals Inc (VNDA)
4.975
-0.26
(-5.06%)
USD |
NASDAQ |
Apr 18, 16:00
4.975
0.00 (0.00%)
After-Hours: 17:37
Vanda Pharmaceuticals Free Cash Flow (Quarterly): -3.985M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.985M |
| September 30, 2023 | -2.074M |
| June 30, 2023 | -13.28M |
| March 31, 2023 | 31.75M |
| December 31, 2022 | 9.153M |
| September 30, 2022 | 12.69M |
| June 30, 2022 | 5.492M |
| March 31, 2022 | 3.971M |
| December 31, 2021 | 26.47M |
| September 30, 2021 | 9.407M |
| June 30, 2021 | 18.72M |
| March 31, 2021 | 9.063M |
| December 31, 2020 | 18.34M |
| September 30, 2020 | 9.128M |
| June 30, 2020 | 23.80M |
| March 31, 2020 | -1.28M |
| December 31, 2019 | 9.723M |
| September 30, 2019 | 5.704M |
| June 30, 2019 | 20.25M |
| March 31, 2019 | 9.25M |
| December 31, 2018 | 15.24M |
| September 30, 2018 | 8.558M |
| June 30, 2018 | -20.68M |
| March 31, 2018 | 1.503M |
| December 31, 2017 | 3.275M |
| Date | Value |
|---|---|
| September 30, 2017 | 1.797M |
| June 30, 2017 | -2.884M |
| March 31, 2017 | -5.835M |
| December 31, 2016 | -1.88M |
| September 30, 2016 | 0.642M |
| June 30, 2016 | -3.373M |
| March 31, 2016 | -4.899M |
| December 31, 2015 | -1.07M |
| September 30, 2015 | -5.725M |
| June 30, 2015 | 11.94M |
| March 31, 2015 | 4.772M |
| December 31, 2014 | -13.72M |
| September 30, 2014 | -7.652M |
| June 30, 2014 | -36.91M |
| March 31, 2014 | -32.04M |
| December 31, 2013 | -12.25M |
| September 30, 2013 | -10.28M |
| June 30, 2013 | -8.092M |
| March 31, 2013 | -9.148M |
| December 31, 2012 | -13.86M |
| September 30, 2012 | -10.18M |
| June 30, 2012 | -12.36M |
| March 31, 2012 | -10.54M |
| December 31, 2011 | -12.43M |
| September 30, 2011 | -7.204M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-13.28M
Minimum
Jun 2023
31.75M
Maximum
Mar 2023
10.16M
Average
9.153M
Median
Dec 2022
Free Cash Flow (Quarterly) Benchmarks
| ADMA Biologics Inc | 16.19M |
| Johnson & Johnson | 5.804B |
| Nektar Therapeutics | -47.28M |
| Invivyd Inc | -59.24M |
| Amicus Therapeutics Inc | 1.727M |